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Objective. The University of Pennsylvania Smell Identification Test (UPSIT) is the most 
commonly used test to detect olfactory impairment in Parkinson’s disease (PD), but the cut-
off score for clinical purposes is often difficult to establish because of age and sex effects. 
The current work aims to study the sensitivity and specificity of the UPSIT Spanish version 
and its accuracy in discriminating PD patients at different age groups from healthy controls 
(HC), and to perform an item analysis.  
Method. Ninety-seven non-demented PD patients and 65 HC were assessed with the UPSIT 
Spanish version. Sensitivity, specificity, and diagnostic accuracy for PD were calculated. 
Multiple regression analysis was used to define predictors of UPSIT scores.  
Results. Using the normative cut-off score for anosmia (≤18), the UPSIT showed a 
sensitivity of 54.6% with a specificity of 100.0% for PD.  We found that, using the UPSIT cut-
off score of ≤25, sensitivity was 81.4% and specificity 84.6% (area under the receiver 
operating characteristic curve=.908). Diagnosis and age were good predictors of UPSIT 
scores (B=-10.948; P<.001; B=-.203; P<.001). When optimal cut-off scores were considered 
according to age ranges (≤60; 61-70; ≥71), sensitivity and specificity values were >80.0% 
for all age groups.  
Conclusions. In the Spanish UPSIT version, sensitivity and specificity are improved when 
specific cut-off scores for different age groups are computed.  
 
 
KEYWORDS: Parkinson’s disease; Elderly/Geriatrics/Aging; Olfaction; Assessment; 
Movement disorders. 
 




Olfactory impairment has been found to be a prodromal manifestation in Parkinson’s 
disease (PD) (Berendse, Roos, Raijmakers, & Doty, 2011; Doty, 2012) and other 
neurodegenerative disorders (Doty, 2012). The prevalence of olfactory deficits in PD is 
estimated to be about 90% (Fullard et al., 2016; Haehner et al., 2009). Olfactory dysfunction 
substantially affects wellbeing and quality of life, reducing enjoyment from food, beverages, 
personal care products, and the natural environment. Moreover, decreased smell function 
increases the risk of danger from fire, environmental toxins, leaking natural gas, and spoiled 
food (Doty, 2017). 
Odour identification tests, such as the University of Pennsylvania Smell Identification Test 
(UPSIT) (Doty, 1995), are used in both research and clinical settings to assess olfactory 
dysfunction in PD patients. The UPSIT has demonstrated high capability in differentiating 
PD patients from healthy subjects (Bohnen, Studenski, Constantine, & Moore, 2008), and 
has been used as a tool for the diagnosis of PD (Doty, Bromley, & Stern, 1995; Silveira-
Moriyama et al., 2008).  
It is well known that aging per se is associated with olfactory decline; McKinnon et al. 
(2010), using data collected from 732 subjects, estimated that the decrease in UPSIT scores 
is around 3.2 points for every 10 years of age (McKinnon et al., 2010). Loss of olfactory 
identification ability is seen from the 5th decade onwards but is most remarkable between 
the 7th and 8th decades of life. In PD patients, it has also been found that UPSIT scores 
decreased as a function of age (Doty et al., 1995).  
Olfactory functions in normal subjects are clearly influenced by gender (Doty, Ford, Preti, & 
Huggins, 1975; Doty, Orndorff, Leyden, & Kligman, 1978; Doty, Green, Ram, & Yankell, 
1982). Sex-related differences in the UPSIT have also been described in PD, with lower 
performance for men (Doty et al., 1995). These results suggest that age and sex should be 
taken into consideration when using olfactory measures as a tool for PD diagnosis. In this 
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setting, Doty et al. (Doty et al., 1995) proposed optimal cut-off scores that best discriminate 
between PD and healthy subjects, according to different age groups and according to 
gender. As far as we know, these results have not been validated in the UPSIT Spanish 
version. 
Considering that performance in smell identification tests are subject to cultural variation, 
the UPSIT has been adapted to several countries (Ogihara, Kobayashi, Nishida, Kitano, & 
Takeuchi, 2011; Picillo et al., 2014; Rodriguez-Violante, Lees, Cervantes-Arriaga, Corona, & 
Silveira-Moriyama, 2011; Silveira-Moriyama et al., 2008, 2010; Yücepur et al., 2012). Even 
though changes in some specific items have improved sensitivity and specificity, it is hard 
to generalise the results to other populations (Picillo et al., 2014; Rodriguez-Violante, 
Gonzalez-Latapi, Camacho-Ordoñez, et al., 2014a; Silveira-Moriyama et al., 2008). 
Furthermore, previous works found a decreased identification of some UPSIT items in 
healthy populations (Picillo et al., 2014; Silveira-Moriyama et al., 2008; Rodriguez-Violante, 
Gonzalez-Latapi, Camacho-Ordonez, et al., 2014b; Kondo, Matsuda, Hashiba, 1998). In this 
sense, the analysis of individual smell scores of UPSIT Spanish version may allow identifying 
items with greater accuracy in PD diagnosis, and items that are culturally unsuitable. 
In the current work, we aim to investigate the sensitivity and specificity of the UPSIT 
Spanish version, its accuracy in discriminating PD patients from healthy controls (HC), age 
and sex related effects on test performance, and individual item reliability. It was 
hypothesised that: (1) PD patients will have poorer performance than HC; (2) the UPSIT will 
discriminate PD patients from healthy controls; (3) Some UPSIT items will show low 
percentage of success in control subjects; (4) Age will have an effect in UPSIT scores; (5) Sex 
will have an effect in UPSIT scores; (6) Diagnostic accuracy will improve when the effects of 
age and sex are considered. 
 
 





The study sample included 97 non-demented PD patients and 65 HC who underwent 
olfactory evaluation.  
PD patients were recruited from an outpatient movement disorders clinic (Parkinson’s 
disease and Movement Disorders Unit, Department of Neurology, Hospital Clinic, Barcelona, 
Catalonia, Spain). HC consisted of individuals who had previously volunteered who take 
part in studies of aging at the “Fundació Salut i Envelliment, Universitat Autònoma de 
Barcelona” (Barcelona, Spain).  
Exclusion criteria for both groups were: (1) significant psychiatric, neurological, or systemic 
comorbidity; (2) low average premorbid intelligence quotient estimated by the Vocabulary 
subtest of the Wechsler Adult Intelligence Scale, 3rd edition (scaled score ≤ 7); and (3) Mini 
Mental State Examination (MMSE) score < 25. Specific exclusion criteria for the olfaction 
test were: (1) history of nasal bone fracture, (2) diagnosis of rhinitis or nasal polyps, and 
(3) upper respiratory tract infections in the two weeks prior to testing.  
The inclusion criteria for PD were: (1) the fulfilment of UK PD Society Brain Bank diagnostic 
criteria for PD (Hughes, Daniel, Kilford, & Lees, 1992); (2) no surgical treatment with deep 
brain stimulation. Exclusion criteria for PD were: (1) Hoehn and Yahr (H&Y) (Hoehn & Yahr, 
1967) score > 3 (defined as mild to moderate bilateral disease with some postural instability 
but physically independent); (2) dementia according to Movement Disorder Society criteria 
(Dubois et al., 2007): (a) PD developed prior to the onset of dementia, (b) PD associated 
with a decreased Global Cognitive Efficiency,  (c) cognitive impairment in more than one 
cognitive domain, (d) impact on daily living resulting from cognitive deficits, over and above 
those imposed by motor and autonomic problems (Dubois et al., 2007).  
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All PD patients were taking antiparkinsonian medication consisting of different 
combinations of L-DOPA, COMT inhibitors, MAO inhibitors, dopamine agonists, and 
amantadine. In order to standardise doses, levodopa equivalent daily dose (LEDD) was 
calculated as suggested by Tomlinson et al. (Tomlinson et al., 2010). All assessments were 
done in the on state. Motor disease severity was evaluated using H&Y staging and the 
Unified Parkinson’s Disease Rating Scale motor section (UPDRS-III). 
The study was approved by the Ethics Committee of the University of Barcelona 
(IRB00003099). All subjects provided written informed consent to participate after full 
explanation of the procedures involved.  
Olfactory and clinical assessment  
Odour identification was assessed using the Spanish version of the University of 
Pennsylvania Smell Identification Test (UPSIT-40) (Doty, 1995).  
The UPSIT is a standardised multiple-choice scratch-and-sniff test consisting of four test 
booklets with 10 items each. In accordance with normative instructions, subjects scratch 
the impregnated area and are asked to select one of four possible answers for each item. 
Following normative data presented in the UPSIT manual (Doty et al., 1995), which includes 
adjustment for age and sex, scores greater than 33 in males and 34 in females are considered 
to reflect normosmia, and scores lower or equal to 18 reflect anosmia. Microsmia ranges 
from 33 or 34 (depending on the subject’s gender) to 19. 
In order to achieve higher cultural familiarity, the Smell Identification Test™ (UPSIT) 
Spanish version commercialised by Sensonics (https://sensonics.com) substitutes some 
items with respect to the original UPSIT. Specifically, in item 13, talcum powder replaces 
liquorice; in item 20, apple replaces gingerbread; in item 24, rubber tire replaces root beer; 
in item 27, raspberry replaces lime; and in item 29, walnut replaces wintergreen. 
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The Beck Depression Inventory II (Beck, Steer, 1996), Starkstein’s Apathy Scale (Starkstein 
et al., 1992), and the Neuropsychiatric Inventory (Cummings et al., 1994) were 
administered to all subjects to explore the presence of psychiatric symptoms.  
Demographic, clinical, and olfactory data analysis 
Statistical analysis of demographic, clinical, and olfactory data were performed using IBM 
SPSS Statistics 24.0.0 (2016; Armonk, NY: IBM Corp). Group differences in demographic and 
clinical variables between HC and PD patients were analysed with independent Student’s t-
tests for quantitative measures or with Pearson’s chi-squared test for categorical measures. 
Bonferroni correction was used to correct for multiple testing. A multiple regression 
analysis with stepwise method was used to define possible UPSIT score predictors in the 
whole sample and in the PD group. Predictors were chosen based on previous literature 
(Deeb et al., 2010; Doty et al., 1978; Doty, 2012; Frye, Schwartz, & Doty, 1990; Hubert, 
Fabsitz, Feinleib, & Brown, 1980; Joyner, 1964; McKinnon et al., 2010) and correlation 
analysis. Age, PD diagnosis, sex, years of education, and smoking status were introduced as 
possible predictors for the whole sample regression. For the PD subsample, PD diagnosis 
was excluded, and clinical measures such as H&Y, UPDRS-III, and LEDD were added.  
UPSIT item analysis 
Sensitivity, specificity, diagnostic accuracy, positive predictive value, and negative 
predictive value for PD were calculated for the UPSIT-40 total score, and for each item. 
Pearson’s chi-squared test was used to compare the percentage of HC and PD patients who 
correctly identified each item of the 40-items UPSIT version.  
Incorrect answers were considered as positive findings (i.e., altered performance), whereas 
correct answers defined negatives. True positives (TP) were defined as the number of PD 
patients who got a wrong response in a certain item; true negatives (TN) as the number of 
HC who got a correct response; false positives (FP) were calculated as the number of HC 
who got a wrong response and, finally, false negatives (FN) were described as the number 
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of PD patients who had a correct answer. The following diagnostic measures were 
calculated: (1) Sensitivity, defined as the probability of testing positive when PD is present: 
TP/(TP+FN); (2) Specificity, defined as the probability of testing negative when PD is 
absent: TN/(FP+TN); (3) Positive predictive value (PPV), calculated as the percentage of 
subjects with a positive test who actually have PD: TP/(TP+FP); (4) negative predictive 
value (NPV), defined as the percentage of subjects with a negative test who do not have PD: 
TN/(TN+FN); finally, (5) overall diagnostic accuracy was defined as the proportion of 
correctly classified subjects among all subjects: (TP+TN)/(TP+TN+FP+FN). 
Results 
Demographic and clinical characteristics. 
There were no differences between groups in sex (X2=3.447; P=.063), age (t=-1.2798; 
P=.437), years of education (t=.639; P=.429), or estimated IQ scores (t=.041; P=.977). 
Regarding psychiatric symptoms, there were significant differences between groups in Beck 
Depression Inventory II (t=-4.1329; P=.001), Starkstein’s Apathy Scale (t=-4.5463; 
P=<.001), and in Cummings’ Neuropsychiatric Inventory scores (t=-6.6537; P<.001). 
Supplementary Table 1. 
Olfactory performance 
PD patients correctly identified 18.6±6.8 UPSIT items and HC 29.8±4.2 (t=11.961; p<.001).  
Considering the normative cut-off score of ≤18, 54.6% of PD patients and no HC were 
identified as anosmic. Supplementary Table 2.  
UPSIT diagnostic measures 
For the normative cut-off score of ≤18 to define anosmia, UPSIT total score had a sensitivity 
of 54.6% with a specificity of 100.0%, a PPV of 100.0%, a NPV of 59.6%, and a diagnostic 
accuracy of 72.8% for PD. The receiver operating characteristic (ROC) curve showed that 
the optimal cut-off score for UPSIT-40 was ≤25 with a sensitivity of 81.4%, a specificity of 
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84.6 %, a PPV of 88.8%, a NPV of 75.3% and a diagnostic accuracy of 82.7% (area under the 
ROC curve = .908). Table 1.  
When considering the whole sample, UPSIT total score correlated negatively with age (r=-
.300; p<.001). In the HC group, significant correlations were found between UPSIT total 
score and age (r=-.406; p=.001) and years of education (r=.296; p=.017). In the PD patient 
group, a negative correlation was found between UPSIT total score and age (r=-.366; 
p<.001). Sex did not achieve significant correlation with UPSIT total score, either in HC 
(r=.221; p=.076) or in PD (r=-.016; P=.875). Diagnosis (B=-10.948; t=-11.333; P<.001) and 
age (B=-.203; t=-4.370; P<.001) were found to be the best predictors of UPSIT scores when 
the whole sample was considered. For the PD patient sample, clinical measures were 
included in the regression analysis, and only age was identified as a significant UPSIT score 
predictor (B=-.250; t= -3.545; P<.001). According to these data, we plotted ROC curves for 
three age groups (≤60, 61-70, and ≥71 years). Table 2 shows cut-off scores with higher 
sensitivity and specificity for each age group. Sensitivity and specificity for PD diagnosis 
considering age groups for each UPSIT cut-off score are represented in Figure 1. In addition, 
we plotted ROC curves considering the same three groups divided by gender. Table 3.  
UPSIT item analysis 
Diagnostic measures and group differences for each item are described in Table 4 and 
Figure 2.  
Items that did not show significant differences between groups in the chi-squared test after 
Bonferroni correction were: Bubble gum (X2=9.727; P=.002), cherry (X2=.063; P=.802), fruit 
juice (X2=8.645; P=.003), cheese (X2=3.580; P=.058), cedar (X2=1.849; P=.174), peach 
(X2=7.183; P=.007), pickle (X2=.404; P=.507), orange (X2=3.836; P=.050), walnut (X2=.059; 
P=.808), lemon (X2=1.652; P=.199), and soap (X2=9.556; P=.002). 
Items with less than 50.0% correct answers in HC were: cedar (44.6%), lemon (40.0%), 
cherry (33.8%), pickle (26.2%), and walnut (23.1%). In particular, according to age 
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grouping, items with an error rate above 50.0% for HC under 60 years old were dill pickle 
(33.3%), walnut (20.8%), and lemon (37.5%); for the middle-age group, pizza (38.1%), dill 
pickle (23.8%), walnut (9.5%), and cherry (28.6%); lastly, for HC above 71, pizza (40.0%), 
cedar (30.0%), dill pickle (20.0%), orange (40.0%), walnut (40.0%), lemon (35.0%), and 
cherry (10.0%). 
Items with sensitivity above 75.0% in the PD patient group were walnut (75.3%), pickle 
(78.4%), and pizza (78.4%). Sensitivity below 25.0% was seen for onion (23.7%). Items with 
a specificity above 90.0% were chocolate (93.8%), coconut (93.8%), lilac (95.4%), onion 
(96.9%), talcum powder (98.5%), and smoke (98.5%). Walnut (23.1%) had a specificity 
below 25.0%. Items with a diagnostic accuracy above 70.0% were paint thinner (71.6%), 
clove (72.3%), and mint (73.3%), and those below 55.0% were onion (53.1%), cherry 
(54.3%), and walnut (54.3%). 
Discussion 
Since olfactory deficits have been found to be a relevant clinical feature in PD (Berendse, 
Roos, Raijmakers, & Doty, 2011; Doty, 2012), there has been growing interest in 
incorporating odour tests in routine protocols both in patient assessment and in data 
collection. Our results show age and sex should be taken into consideration when using 
UPSIT Spanish version as a tool for identifying olfactory deficits associated with PD. 
In the current study, the normative cut-off score of anosmia proposed by the UPSIT manual 
(≤18) demonstrated high specificity (100.0%) and low sensitivity (54.6%). In our sample, 
the optimal cut-off score was identified as ≤25, with a diagnostic accuracy of 82.7%, a 
sensitivity of 81.4%, and a specificity of 84.6%. This observed sensitivity is similar to that 
found in a Mexican population using the same cut-off score (Rodriguez-Violante, Gonzalez-
Latapi, Camacho-Ordonez, et al., 2014a, 2014b). In an Italian study, the cut-off score of ≤21 
differentiated PD and HC with similar sensitivity (82.0%) and specificity (88.2%) (Picillo et 
al., 2014). Given that cross-cultural aspects may influence these results (Rodriguez-
Effects of ageing and sex on olfaction in PD 
11 
 
Violante, Gonzalez-Latapi, Camacho-Ordoñez, et al., 2014a), it could be of interest to 
perform a more detailed analysis of the UPSIT-40 items to identify those with less capability 
to detect olfactory deficits in a given population due to cultural biases.  
We performed an item analysis similar to previous works (Kondo, Matsuda, Hashiba, 1998; 
Picillo et al., 2014; Rodriguez-Violante, Gonzalez-Latapi, Camacho-Ordonez, et al., 2014b; 
Silveira-Moriyama et al., 2008). Our results showed that some items had a rate of correct 
answers of less than 50.0% in HC (cedar, lemon, cherry, dill pickle and walnut), specifically, 
the three age groups coincided on dill pickle and walnut. Such items showed no significant 
differences in the percentage of success between HC and PD patients. As has been proposed 
in the literature (Picillo et al., 2014), a low percentage of success in control subjects may be 
an indicator of culturally unsuitable items. A decreased ability to identify of some odours 
has been reported as well in Italian (Picillo et al., 2014), Brazilian (Silveira-Moriyama et al., 
2008), Mexican (Rodriguez-Violante, Gonzalez-Latapi, Camacho-Ordonez, et al., 2014b), and 
Japanese (Kondo, Matsuda, Hashiba, 1998) control subjects. Out of the five items with low 
identification rates by HC in our study, three items (cherry, cedar, lemon) also showed a low 
percentage of correct identification in a previous study obtained from an Italian population 
(Picillo et al., 2014). Rodríguez-Violante et al. also found that cherry, walnut, and dill pickle 
were identified by less than 50.0% of subjects in a Mexican population (Rodriguez-Violante, 
Gonzalez-Latapi, Camacho-Ordonez, et al., 2014b). In Brazil, Silveira-Moriyama et al. found 
an identification rate of less than 50.0% in cedar, dill pickle, and lemon as well (Silveira-
Moriyama et al., 2008). In this sense, a large percentage (86.0%) of HC fell in the microsmic 
range of performance, with only a small number (13.8%) being classified as normosmic. 
This increased rate of microsmia may reflect, among other reasons, the impact of cultural 
differences on UPSIT performance. These findings suggest a need to provide and to promote 
the use of country-specific normative data. 
Our results show that UPSIT performance was explained mainly by group, but also by age. 
Contrary to previous studies (Campabadal et al., 2017; Sharma & Turton, 2012; Silveira-
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Moriyama et al., 2008), clinical measures such as motor scales and disease duration did not 
significantly predict smell identification performance in our PD subsample. One explanation 
could be that olfactory loss is an early symptom that progresses mainly in prodromal stages 
and may reach maximum severity levels even earlier than motor symptoms, which progress 
through advanced stages (Doty, Deems, & Stellar, 1988).  Further studies in de novo samples 
could help identify a more accurate cut-off score for PD patients in initial stages, which could 
eventually have a positive impact on their quality of life. 
Age contribution to olfactory deficits is well known both in normal subjects (McKinnon et 
al., 2010; Sorokowska et al., 2015) and in PD patients (Doty et al., 1995). This is 
demonstrated by the fact that, in the original English version, discriminatory UPSIT scores 
are presented for different age groups (Doty et al., 1995). Even though changes in some 
specific items have been made, these age-related discrimination criteria have not been 
reviewed for the Spanish version. 
Age-group analysis showed that the UPSIT-40 cut-off score of ≤25 demonstrated higher 
sensitivity for all age ranges than the normative cut-off score for anosmia. When cut-off 
scores for each age group were considered, sensitivity and specificity values were above 
80.0% for all age groups. These values were similar when groups were classified by age and 
gender. In particular, our results show cut-off scores for the youngest group (≤60 years) 
were 29 for males and 30 for females; for the intermediate age group (61-70 years), they 
were 22 for males and 26 for females; and for the oldest group (≥71 years) they were 24 
and 27, respectively. Cut-off scores for all groups were similar but below those proposed by 
Doty et al. (Doty et al., 1995). With a sample of 180 PD patients and 612 HC, Doty et al. 
(1995) found that the sensitivity and specificity of the UPSIT in distinguishing between male 
PD patients and HC under the age of 61 years was 91.0% and 88.0%, respectively (cut-off 
score 31). For females of the same age, the corresponding values were 79.0% and 85.0% 
(cut-off score 33). Sensitivity and specificity of the UPSIT-40 for subjects between 61 and 
70 years of age were 81.0% and 82.0% for males (cut-off score 25) and 80.0% and 88.0% 
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for females, respectively (cut-off score 30). Finally, for subjects older than 71, sensitivity 
and specificity for males were 76.0% and 78.0% (cut-off score 22), and 78.0% and 82.0% 
for females (cut-off score 25) (Doty et al., 1995). Considering that the onset of motor 
features in PD takes place around the age of 60, there is a need for developing more accurate 
procedures for detecting olfactory impairment in young PD patients and in the prodromal 
stages.  
Screening for potential early indicators of PD such as olfaction, constipation or sleep 
disturbances facilitates the identification of individuals at high risk for PD who could 
participate in medical trials addressed to prevent or slow disease progression (Ross et al., 
2008). Therefore, although the UPSIT has high capability in differentiating PD patients from 
healthy controls, it should be used within the context of a comprehensive clinical 
assessment.  
In conclusion, our results demonstrate that the sensitivity and specificity of the UPSIT 
Spanish version were improved when specific cut-off scores for different age and sex groups 
were considered.  
Limitations of this study include the fact that most of our PD patients are in mild to moderate 
stages of the disease. Since the PD patients of our study were already identified as having 
PD, our findings cannot address the issue of early diagnosis of PD. Further studies examining 
early clinical or prodromal stages of PD are needed to address this question. In this study 
we have excluded patients with low IQ and dementia; thus, our findings are not 
generalizable to the whole PD population. Finally, our data is preliminary, and the proposed 
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Table 1. Diagnostic accuracy measures for UPSIT-40 
FN: false negative; FP: false positive; HC: healthy controls; NPV: negative predictive value; 
PD: Parkinson’s disease; PPV: positive predictive value; TN: true negative; TP: true 
positive; UPSIT: University of Pennsylvania Smell Identification Test; UPSIT-40 (cut-off 

























UPSIT version TP TN FP FN 
Diagnostic 
accuracy Sensitivity Specificity PPV NPV 
UPSIT-40 (cut-off ≤18) 53 65 0 44 72.8 54.6 100.0 100.0 59.6 
UPSIT-40 (cut-off ≤25) 79 55 10 18 82.7 81.4 84.6 88.8 75.3 
Table 2. Optimal cut-off scores and associated sensitivity and specificity for PD diagnosis 
for three age groups. 
Age group Cut-off score Sensitivity (%) Specificity (%) AUROC 
≤60 years  29 83.3 87.5 0.905 
61-70 years  25 82.1 81.0 0.903 
≥71 years  22 85.7 85.0 0.954 
AUROC: area under the receiver operating characteristic curve; HC: healthy controls; PD: 
Parkinson’s disease. Optimal cut-off scores and associated sensitivity and specificity were 
calculated through ROC curve analysis for three age groups: ≤60 years (PD=30; HC=24), 


























Table 3. Optimal cut-off scores and associated sensitivity and specificity for PD diagnosis 
considering age and gender measures.  
Age group Sample size Cut-off score Sensitivity (%) Specificity (%) AUROC 
 M  F M F M F M F M F 
Whole sample 32/62 33/35 24 27 80.6 88.6 81.2 87.9 .891 .922 
≤60 years  9/25 15/5 29 30 84.0 80.0 77.8 80.0 .889 .847 
61-70 years  12/23 9/16 22 26 82.6 87.5 91.7 88.9 .897 .917 
≥71 years  11/14 9/14 24 27 100.0 92.9 81.8 77.8 .987 .929 





























Table 4. Item analysis of the UPSIT Spanish version in PD. 
Items marked in blue showed no significant differences in the percentage of correct answers 
between HC and PD patients. FN: false negative; FP: false positive; HC: healthy controls; 
Item Label TP TN FP FN 
Diagnostic 
Accuracy Sensitivity Specificity PPV NPV 
Chi-square/P 
value 
1 Pizza 76 33 32 21 67.3 78.4 50.8 70.4 61.1 14.85/<.001 
2 Bubble gum 35 56 9 62 56.2 36.1 86.2 79.5 47.5 9.73/.002 
3 Menthol 56 54 11 41 67.9 57.7 83.1 83.6 56.8 26.73/<.001 
4 Cherry 66 22 43 31 54.3 68.0 33.8 60.6 41.5 .06/.802 
5 Motor oil 58 47 18 38 65.2 60.4 72.3 76.3 55.3 16.65/<.001 
6 Mint 61 57 8 35 73.3 63.5 87.7 88.4 62.0 41.54/<.001 
7 Banana 42 56 9 54 60.9 43.8 86.2 82.4 50.9 16.01/<.001 
8 Clove 63 54 11 34 72.2 64.9 83.1 85.1 61.4 36.18/<.001 
9 Leather 38 57 8 59 58.6 39.2 87.7 82.6 49.1 13.82/<.001 
10 Coconut 41 61 4 56 63.0 42.3 93.8 91.1 52.1 25.30/<.001 
11 Onion 23 63 2 74 53.1 23.7 96.9 92.0 46.0 12.69/<.001 
12 Fruit juice 51 46 19 46 59.9 52.6 70.8 72.9 50.0 8.64/.003 
13 Talcum powder 27 64 1 70 56.2 27.8 98.5 96.4 47.8 18.82/<.001 
14 Cheese 55 38 27 42 57.4 56.7 58.5 67.1 47.5 3.58/.058 
15 Cinnamon 50 56 8 47 65.8 51.5 87.5 86.2 54.4 25.51/<.001 
16 Gasoline 55 57 8 42 69.1 56.7 87.7 87.3 57.6 32.27/<.001 
17 Strawberry 57 46 19 40 63.6 58.8 70.8 75.0 53.5 13.63/<.001 
18 Cedar 64 29 36 33 57.4 66.0 44.6 64.0 46.8 1.85/.174 
19 Chocolate  31 61 4 66 56.8 32.0 93.8 88.6 48.0 15.30/<.001 
20 Apple 51 53 12 46 64.2 52.6 81.5 81.0 53.5 19.06/<.001 
21 Lilac 37 62 3 60 61.1 38.1 95.4 92.5 50.8 23.53/<.001 
22 Turpentine 66 41 24 30 66.5 68.8 63.1 73.3 57.7 15.93/<.001 
23 Peach 44 49 16 53 57.4 45.4 75.4 73.3 48.0 7.18/.007 
24 Rubber tire 61 44 21 36 64.8 62.9 67.7 74.4 55.0 14.56/<.001 
25 Pickle 76 17 48 21 57.4 78.4 26.2 61.3 44.7 .40/.507 
26 Pineapple 51 56 9 46 66.0 52.6 86.2 85.0 54.9 25.04/<.001 
27 Raspberry 32 58 7 65 55.6 33.0 89.2 82.1 47.2 10.51/.001 
28 Orange 51 41 24 46 56.8 52.6 63.1 68.0 47.1 3.84/.050 
29 Walnut 73 15 50 24 54.3 75.3 23.1 59.3 38.5 .06/.808 
30 Watermelon 40 57 8 57 59.9 41.2 87.7 83.3 50.0 15.62/<.001 
31 Paint thinner 58 58 7 39 71.6 59.8 89.2 89.2 59.8 38.93/<.001 
32 Grass 55 55 10 42 67.9 56.7 84.6 84.6 56.7 27.65/<.001 
33 Smoke 42 64 1 55 65.4 43.3 98.5 97.7 53.8 34.81/<.001 
34 Pine 59 44 21 38 63.6 60.8 67.7 73.8 53.7 12.66/<.001 
35 Grape 65 41 23 32 65.8 67.0 64.1 73.9 56.2 15.02/<.001 
36 Lemon 67 26 39 29 57.8 69.8 40.0 63.2 47.3 1.65/.199 
37 Soap 59 41 23 38 62.1 60.8 64.1 72.0 51.9 9.56/.002 
38 Natural gas 43 57 8 54 61.7 44.3 87.7 84.3 51.4 18.50/<.001 
39 Rose 60 46 19 37 65.4 61.9 70.8 75.9 55.4 16.58/<.001 
40 Peanut 44 57 8 53 62.3 45.4 87.7 84.6 51.8 19.51/<.001 
NPV: negative predictive value; PD: Parkinson’s disease; PPV: positive predictive value; TN: 
true negative; TP: true positive.  
Pearson’s chi-squared tests were used to compare the percentage of HC and PD patients 
who correctly identified each item. P-values that survive Bonferroni correction for 





UPSIT sensitivity and specificity for PD diagnosis considering age group. 
UPSIT: University of Pennsylvania Smell Identification Test; UPSIT-40 (cut-off ≤18): 
normative cut-off; UPSIT-40 (cut-off ≤25): optimal cut-off for this study sample; UPSIT-40 
(cut-off per age group): optimal cut-off score for each age group. 
Age groups and corresponding group sizes: ≤60 years (PD=30; HC=24), 61-70 years 





Percentage of subjects who correctly identified each item of the UPSIT. 
* Items that did not show significant differences between groups in the chi-squared test 
after Bonferroni correction 




Supplementary Table 1. Demographic and clinical characteristics of PD patients and HC  
 PD (n=97) HC (n=65) Test stats/P-value 
Age, yrs., mean (SD) 65.6 (9.6) 64.2 (11.1) 1.28/.437a 
Education, yrs., mean (SD) 11.4 (5.3) 12.1 (4.5) .64/.429a 
Vocabulary subtest, mean (SD) 45.2 (9.1) 45.2 (7.9) .04/.977 a 
Sex, male, n (%) 62 (63.9) 32 (49.2) 3.45/.063 b 
Smoking status  
(nonsmoker/ex-smoker/smoker) 
60/6/30 24/5/10 1.77/.413 
Disease duration, yrs., mean (SD) 8.7 (5.9) NA NA 
Age of onset, yrs., mean (SD) 56.7 (11.3) NA NA 
UPDRS-III, mean (SD) 17.4 (9.5) NA NA 
Hoehn & Yahr stage, n 
1/1.5/2/2.5/3/4 
8/2/51/5/24/0 NA NA 
LEDD, mg, mean (SD) 765.9 (452.2) NA NA 
Abbreviations: HC: healthy controls; LEDD: L-DOPA equivalent daily dose; NA: not applicable; PD: 
Parkinson’s disease; UPDRS part III: Unified Parkinson’s Disease Rating Scale motor section. Data 
are presented as mean (SD), except for sex (number of cases and percentage) and Hoehn and Yahr 
staging (number of cases). 
a. Independent Student’s t-tests were used for continuous variables when comparing HC with 
all PD patients. 
















Supplementary table 2. Olfactory measures in PD and HC. 





UPSIT-40 18.6 (6.8) 29.8 (4.2) 11.96/<.001 a 0.69 
Olfactory status according to UPSIT-40 normative data, n (%)  
 Normosmia 2 (2.1) 9 (13.8)   
 Mild hyposmia 4 (4.1) 25 (38.5)   
 Moderate hyposmia  12 (12.4) 22 (33.8) 80.97/<.001b  
 Severe hyposmia 26 (26.8) 9 (13.8)   
 Anosmia 53 (54.6) 0 (0)   
Abbreviations: HC, healthy controls; PD, Parkinson’s disease; UPSIT-40, University of 
Pennsylvania Smell Identification Test. Data are presented as mean (SD) or n (%).  
a. Independent t-tests were used for continuous variables when comparing HC with 
all PD patients. 
b. Pearson’s chi-squared tests were used for categorical variables. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
